Q3 2019 Investor Presentation

> Proven capital management Capital Deployment Investment for Growth ☐ New Products ☐ Geographic expansion Acquisitions Free Cash Flow returned to Shareholders Last twelve months combined dividend and stock repurchase = 67% of free cash flow Increasing Dividend YTD FY2019 dividend payout ratio of 41% of adjusted net income Dividend per share increased by 6% over prior year Combined dividend and buy-back over rolling 5 years = 65% of free cash flow © 2019 ResMed I Q3 2019 Investor Presentation | 41 ResMed

View entire presentation